Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	23
Overall Study	STARTED	300 mg Spesolimab (BI 655130) SD	24
Overall Study	STARTED	450 mg Spesolimab (BI 655130) q4w	23
Overall Study	STARTED	1200 mg Spesolimab (BI 655130) q4w	28
Overall Study	Treated	Placebo	23
Overall Study	Treated	300 mg Spesolimab (BI 655130) SD	24
Overall Study	Treated	450 mg Spesolimab (BI 655130) q4w	23
Overall Study	Treated	1200 mg Spesolimab (BI 655130) q4w	27
Overall Study	COMPLETED	Placebo	18
Overall Study	COMPLETED	300 mg Spesolimab (BI 655130) SD	21
Overall Study	COMPLETED	450 mg Spesolimab (BI 655130) q4w	22
Overall Study	COMPLETED	1200 mg Spesolimab (BI 655130) q4w	20
Overall Study	NOT COMPLETED	Placebo	5
Overall Study	NOT COMPLETED	300 mg Spesolimab (BI 655130) SD	3
Overall Study	NOT COMPLETED	450 mg Spesolimab (BI 655130) q4w	1
Overall Study	NOT COMPLETED	1200 mg Spesolimab (BI 655130) q4w	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03482635/flow